Home › Merck to buy Idenix Pharma for $3.85 billion
 

Keywords :   


Merck to buy Idenix Pharma for $3.85 billion

2014-06-09 15:33:35| Biotech - Topix.net

Merck & Co. says the Cambridge, Massachusetts, company has built a promising portfolio of hepatitis C treatments, including three in clinical testing Merck will spend $24.50 per share in cash for each share, which closed at $7.23 Friday.

Tags: buy billion pharma merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »